Search Details

Word: bayer (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...increased supply of the antibiotic Cipro has become more apparent. No one yet knows how extensive a biological attack might be—and if any significant attack occurred, hoarding of the antibiotic by those unaffected only would only make a shortage of the drug worse. Although Bayer A.G., the German-based company that holds the Cipro patent, has assured the public that it has the capacity to meet demand, the U.S. must be prepared if its order for 100 million tablets by mid-December cannot be filled—or if more Cipro is needed...

Author: By The CRIMSON Staff, CRIMSON STAFF WRITER | Title: Paying the Price for Cipro | 10/24/2001 | See Source »

However, one approach to maintaining American preparedness was indicated by yesterday’s agreement between Bayer and the Canadian government. Last week, citing “extraordinary and unusual times,” the Canadian government announced it would ignore the Bayer patent and authorized the production of 1 million generic tablets by a Canadian company. After high-intensity negotiations, Canada yesterday reversed its position as Bayer agreed to supply the tablets within 48 hours—before the generic tablets would have been ready—at a discounted price...

Author: By The CRIMSON Staff, CRIMSON STAFF WRITER | Title: Paying the Price for Cipro | 10/24/2001 | See Source »

Should Bayer’s production capacity prove insufficient, the U.S. should not hesitate to mandate licensing of the patent and authorize production by other companies in order to ensure Americans’ safety. At the same time, however, it should pay Bayer a fair price for the drugs—such as the below-market price it has already negotiated. The added cost of compensating Bayer for its losses would be more than offset by the continued development of medicines that are needed to protect Americans from bioterrorism...

Author: By The CRIMSON Staff, CRIMSON STAFF WRITER | Title: Paying the Price for Cipro | 10/24/2001 | See Source »

...certain cities, notably New York. Bayer, Cipro's manufacturer, is pumping up production by 25%, probably in part to meet potential demand from the military for treating U.S. troops abroad...

Author: /time Magazine | Title: Burning Questions | 10/22/2001 | See Source »

...Bayer has patent rights over Cipro for at least another year - although those rights may now be challenged. Tuesday, U.S. Senator Chuck Schumer of New York announced there is a section of federal law allowing the government to buy generic versions of patented drugs. If his proposal is approved, Schumer says, the public would not have to worry about buying Cipro, because the government would have a supply large enough to go around...

Author: /time Magazine | Title: Drug of the Moment: Cipro | 10/18/2001 | See Source »

Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Next